Shira Israella Klein-Bentsur v. Keryx Biopharmaceuticals Inc. et al: Discovery Application

Ex Parte Application by Shira Israella Klein-Bentsur to take discovery from Keryx Biopharmaceuticals Inc., Urogen Pharma Ltd., XTL Biophannaceuticals LLC, Nextgen Healthcare Information Systems LLC, E-QURE Corp., Stemline Therapeutics, Inc., Citibank N.A., HSBC Bank Plc, JPMorgan Chase & Co., TD Bank, N.A., Bank Leumi, Merrill Lynch, Wells Fargo, Oppenheimer & Co., UBS AG, Bank of New York Mellon, ABN AMRO Securities LLC, First Trade Union Bank, Bank of Ireland, Santander Bank, N.A., RBC Capital Markets, and Cornick, Garber & Sandler, LLP for use in legal proceedings in Israel involving Ron Bentsur, filed at the U. S. District Court for the Southern District of New York.


  • 247
    November 28, 2018
    Shira Israella Klein-Bentsur
    Xx Xx Xx
    Keryx Biopharmaceuticals Inc., Urogen Pharma Ltd., XTL Biophannaceuticals LLC, Nextgen Healthcare Information Systems LLC, E-QURE Corp., Stemline Therapeutics, Inc., Citibank NA, HSBC Bank Plc, JPMorgan Chase & Co., TD Bank, NA, Bank Leumi, Merrill Lynch, Wells Fargo, Oppenheimer & Co., UBS AG, Bank of New York Mellon, ABN AMRO Securities LLC, First Trade Union Bank, Bank of Ireland, Santander Bank, NA, RBC Capital Markets, Cornick, Garber & Sandler, LLP
    Oren Warshavsky, Gonzalo Zeballos, BakerHostetler